CTXR · Citius Pharmaceuticals, Inc.

Summary

Citius Pharmaceuticals, Inc. filed an 8-K on March 10, 2026, disclosing under Item 8.01 that its majority-owned subsidiary Citius Oncology, Inc. (Nasdaq: CTOR) issued a press release announcing positive topline results. Exhibit 99.1 contains the press release dated March 10, 2026.

Key takeaways

• Citius Oncology, Inc. (Nasdaq: CTOR) issued press release on March 10, 2026
• Positive topline results announced by subsidiary
• Majority-owned by Citius Pharmaceuticals, Inc.
• Exhibit 99.1: Press release dated March 10, 2026